Federal contractor · public award history
RIDGEBACK BIOTHERAPEUTICS LP
Parent: RIDGEBACK BIOTHERAPEUTICS LP Unique Entity Identifier (UEI)CLKVVJ61FHN4
- Awards we know about
- 2
- Typical size
- $16.88M
- Middle of their public awards
- Dollars on those awards
- $33.76M
Most of their awards we can see fall roughly between $15.43M and $18.32M.
SAM.gov registration
- Status
- Active
- Purpose of registration
- All awards (Z2)
- Registration expires
- Mar 2, 2027
- Activation date
- Mar 4, 2026
- Primary NAICS (SAM)
- Research and Development in Biotechnology (except Nanobiotechnology)541714
Other NAICS on file
Business types (SAM)
Registration fields from the official SAM.gov public entity extract (monthly bulk). Not a substitute for live SAM checks.
Continue contractor research
Use the verified identifiers and public award record to investigate documented incumbents, compare competitors, or identify possible teaming partners. This is a research starting point, not a capability or partner recommendation.
These official USAspending contract records do not rate capability or past performance and do not tell you whether to team or bid.
Awarding agencies
- Department of Health and Human Services (2)
Industries & product codes
Award history
- Department of Health and Human Services$19.77MSep 9, 2025Procurement Instrument Identifier (PIID)75A50120C00009Research and Development in Nanotechnology541713Health R&D Services; Health Care Services; Experimental DevelopmentAN13Contract awardUSAspending ↗
CMC EFFORTS FOR MAB114 FOR THE DEVELOPMENT AND TREATMENT OF EBOLA.
- Department of Health and Human Services$13.99MAug 15, 2025Procurement Instrument Identifier (PIID)75A50119C00059Research and Development in Nanotechnology541713Health R&D Services; Health Care Services; Experimental DevelopmentAN13Contract awardUSAspending ↗
CMC EFFORTS FOR MAB114 DEVELOPMENT FOR THE TREATMENT OF EBOLA.
For research only. This is not legal advice, a past-performance review, or a recommendation to team or bid. Check USAspending and SAM.gov.